Showing results (491-500 of 504) with videos related to
Sort By:
Pageof 51
Journal of the American College of Cardiology|March 25, 1992
Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery diseaseJ Genest, J R McNamara, J M Ordovas, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 1997
Efficacy and safety of a new hydroxymethylglutaryl-coenzyme A reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: comparison with fenofibrateT C Ooi, T Heinonen, P Alaupovic, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|February 2, 2008
Vascular calcifications in homozygote familial hypercholesterolemiaZ Awan, K Alrasadi, G A Francis, et al.Atherosclerosis|May 11, 1990
DNA polymorphisms of the apolipoprotein B gene in patients with premature coronary artery diseaseJ J Genest, J M Ordovas, J R McNamara, et al.Journal of Medical Genetics|August 19, 2008
A PCSK9 variant and familial combined hyperlipidaemiaM Abifadel, L Bernier, G Dubuc, et al.Circulation|June 11, 1992
Familial lipoprotein disorders in patients with premature coronary artery diseaseJ J Genest, S S Martin-Munley, J R McNamara, et al.JAMA|January 10, 1996
Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemiaR G Bakker-Arkema, M H Davidson, R J Goldstein, et al.QJM : Monthly Journal of the Association of Physicians|September 12, 2007
Venous thromboembolism in association with features of the metabolic syndromeJ G Ray, E Lonn, Q Yi, et al.Clinical Genetics|July 1, 1997
Geographic distribution of French-Canadian low-density lipoprotein receptor gene mutations in the Province of QuebecM C Vohl, S Moorjani, M Roy, et al.Circulation|March 10, 2001
Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery diseaseS M Clee, A H Zwinderman, J C Engert, et al.Pageof 51